CSI Market
Sign In | Register

Evoke Pharma Inc (EVOK) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access EVOK Annual Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how Evoke Pharma Inc manages its resources, obligations, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2025)
(Jun 30 2025) (Mar 31 2025) (Dec 31 2024) (Sep 30 2024)
Assets
Cash & cash equivalent11.58
Cash & Short-term Investments11.00
Accounts receivable3.19
Inventories0.60
Other Current Assets0.03
Prepaid Expense, Current AS0.14
Total Current Assets15.54
Deferred Costs, Noncurrent AS0.00
Other Assets, Noncurrent0.11
Operating Lease Right Of Use Asset0.11
Total Assets15.65
Liabilities
Accounts Payable and Accrued Liabilities, Current LI3.92
Accrued Liabilities, Current0.77
Notes Payable, Current NO5.00
Other Liabilities, Current2.55
Total Current Liabilities12.24
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Operating Lease Liability Current0.07
Operating Lease Liability Noncurrent0.05
Total Liabilities12.29
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock136.19
Retained Earnings / Accumulated Deficit-132.82
Other Equity0.00
Common Stockholder's Equity3.36
Total Stockholder's Equity3.36
Liabilities & Stockholder's Equity15.65
4 historic quarters locked

Sign in to unlock the full Evoke Pharma Inc balance sheet history.

Sign In Create Free Account

About Evoke Pharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20250930)
  • Filed with the SEC: November 13, 2025
  • Source: evok-20250930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-25-278802

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.